bit.bio is an award-winning human synthetic biology company - their mission: coding cells for novel cures. They have developed an end-to-end platform for the creation of any human cell type. With their cutting-edge and patent-protected opti-ox precision cell programming technology, they can deterministically program human iPSCs into a chosen cell identity with unprecedented biological consistency at an industrial scale, and approximately 10 times faster than conventional methods. Their platform has the potential to unlock a new generation of medicines.